| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |